Eli Lilly has dominated headlines in recent months, recently taking the crown as the most valuable company in the biopharma industry by market cap. | Two investigational cardiometabolic drugs from Eli ...

According to MarketsandMarkets™, the Human Microbiome Drugs Market is projected to grow from about USD 0.35 billion in 2025 ...

AbbVie and Gilead Sciences each used the holiday season to reward their pipelines with a new clinical-stage cancer drug. | ...

Biosplice Therapeutics, Inc. ("Biosplice"), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK kinases, announced today that ...

According to MarketsandMarkets, the Human Microbiome Drugs Market is projected to grow from about USD 0.35 billion in 2025 to USD 2.13 billion ...

Eli's Hormometer is an innovative kit and app system for checking hormone levels at home. While not intended as a clinical or ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

The process of aging is associated with a decline in immune functions and persistent low-level inflammation. Now, researchers from Japan have discovered a strain of Lentilactobacillus capable of ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...

A new meeting report was published in Volume 17, Issue 12 of Aging-US on December 23, 2025, titled "Cellular senescence meets ...

Infections that do not go away or abnormal immune responses may cause chronic inflammation. Chronic inflammation can lead to diseases like asthma, heart disease, and rheumatoid arthritis. Avoiding ...